Post
The Wall Street Journal
wsj.com
did:plc:i3fhjvvkbmirhyu4aeihhrnv
The company said the agency wouldn’t review its application on the grounds that the study testing the shot wasn’t sufficient. on.wsj.com/4kDMGPN
https://on.wsj.com/4kDMGPN
2026-02-10T23:02:08.055Z